Twelve years after the publication of her award-winning first novel “White Teeth,” Zadie Smith returns to the racially mixed, multicultural northwest sector of London where she grew up in the 1970s and 1980s. Her newest novel is titled simply “NW.” It took more her than seven years to write, and she has likened it to a “problem play.” The plot revolves around four people in their 30s who come from the same subsidized housing project. Through their eyes, she explores the complexities of the class system in London and how people from similar backgrounds can come to have vastly different destinies.


  • Zadie Smith author of "White Teeth," "The Autograph Man," and "On Beauty.

Related Links

Topics + Tags


comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Oct 02 2015Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Oct 02 2015Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.

Steven Lee Myers: “The New Tsar”

Thursday, Oct 01 2015Russian President Putin is widely popular in Russia, despite his ruthless reputation abroad. A former Moscow bureau chief for The New York Times explains how Putin rose from obscurity to become one of the world’s most powerful and enigmatic leaders.

The Debate Over Drug Pricing

Thursday, Oct 01 2015The owner of a drug company has come under fire for dramatically raising the price of medicine that fights deadly infections. And the prices of some heart medications have also spiked. We look at the renewed controversy over high drug prices in the U.S.